adenine has been researched along with Brain Diseases in 11 studies
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of thiamine deficiency on rat brain DNA and RNA synthesis was investigated." | 7.65 | Reversible impairment of cerebral DNA synthesis in thiamine deficiency. ( Henderson, GI; Schenker, S, 1975) |
| " (S)-HPMPA inhibited the development of tail lesions caused by vaccinia virus if it was administered intraperitoneally or subcutaneously at a dosage as low as 5 mg/kg per day." | 5.28 | Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo. ( De Clercq, E; Holý, A; Rosenberg, I, 1989) |
| "The effect of thiamine deficiency on rat brain DNA and RNA synthesis was investigated." | 3.65 | Reversible impairment of cerebral DNA synthesis in thiamine deficiency. ( Henderson, GI; Schenker, S, 1975) |
| " Additionally, debate exists regarding the recommended dosing strategy for ibrutinib for this indication with disease remission demonstrated at 560 mg and 420 mg." | 1.51 | Ibrutinib for the treatment of Bing-Neel syndrome, a complication of Waldenström macroglobulinemia: Patient case report. ( Arnall, JR; Hartsell, L; Janes, A; Larck, C; Park, S, 2019) |
| " (S)-HPMPA inhibited the development of tail lesions caused by vaccinia virus if it was administered intraperitoneally or subcutaneously at a dosage as low as 5 mg/kg per day." | 1.28 | Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo. ( De Clercq, E; Holý, A; Rosenberg, I, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Creuzet, E | 1 |
| Nourrisson, C | 1 |
| Chaleteix, C | 1 |
| Poirier, P | 1 |
| Moniot, M | 1 |
| Carella, M | 1 |
| Stefoni, V | 1 |
| Broccoli, A | 1 |
| Argnani, L | 1 |
| Zinzani, PL | 1 |
| Jing, YH | 1 |
| Zhang, L | 1 |
| Gao, LP | 1 |
| Qi, CC | 1 |
| Lv, DD | 1 |
| Song, YF | 1 |
| Yin, J | 1 |
| Wang, DG | 1 |
| Gaye, E | 1 |
| Le Bot, A | 1 |
| Talarmin, JP | 1 |
| Le Calloch, R | 1 |
| Belaz, S | 1 |
| Dupont, M | 1 |
| Tattevin, P | 1 |
| Boudin, L | 1 |
| Patient, M | 1 |
| Roméo, E | 1 |
| Bladé, JS | 1 |
| de Jauréguiberry, JP | 1 |
| Hartsell, L | 1 |
| Janes, A | 1 |
| Larck, C | 1 |
| Park, S | 1 |
| Arnall, JR | 1 |
| Ciccarelli, R | 1 |
| Ballerini, P | 1 |
| Sabatino, G | 1 |
| Rathbone, MP | 1 |
| D'Onofrio, M | 1 |
| Caciagli, F | 1 |
| Di Iorio, P | 1 |
| Brunell, P | 1 |
| McKeran, RO | 1 |
| Henderson, GI | 1 |
| Schenker, S | 1 |
| De Clercq, E | 1 |
| Holý, A | 1 |
| Rosenberg, I | 1 |
1 review available for adenine and Brain Diseases
| Article | Year |
|---|---|
Involvement of astrocytes in purine-mediated reparative processes in the brain.
Topics: Adenine; Adenosine Triphosphate; Animals; Astrocytes; Brain; Brain Diseases; Brain Injuries; Cell Di | 2001 |
1 trial available for adenine and Brain Diseases
| Article | Year |
|---|---|
Antiviral drugs for the neonate--the risk-benefit ledger.
Topics: Adenine; Animals; Antiviral Agents; Arabinose; Brain; Brain Diseases; Clinical Trials as Topic; Cyta | 1975 |
9 other studies available for adenine and Brain Diseases
| Article | Year |
|---|---|
Cerebral aspergillosis in a patient on ibrutinib therapy.
Topics: Adenine; Adrenal Cortex Hormones; Aged; Aspergillosis; Aspergillus fumigatus; Brain Diseases; Humans | 2021 |
A Case of Bing-Neel Syndrome Treated Successfully With Ibrutinib Monotherapy Following Intensive Chemoimmunotherapy.
Topics: Adenine; Aged; Brain Diseases; Central Nervous System Neoplasms; Female; Humans; Immunotherapy; Pipe | 2021 |
Autophagy plays beneficial effect on diabetic encephalopathy in type 2 diabetes: studies in vivo and in vitro.
Topics: Adenine; Animals; Arcuate Nucleus of Hypothalamus; Autophagy; Blotting, Western; Brain Diseases; Cho | 2017 |
Cerebral aspergillosis: An emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia?
Topics: Adenine; Aged; Brain Diseases; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Neuroaspergillo | 2018 |
Efficacy of ibrutinib as first-line treatment of tumoral Bing-Neel syndrome.
Topics: Adenine; Aged; Brain; Brain Diseases; Humans; Magnetic Resonance Imaging; Male; Piperidines; Pyrazol | 2018 |
Ibrutinib for the treatment of Bing-Neel syndrome, a complication of Waldenström macroglobulinemia: Patient case report.
Topics: Adenine; Brain Diseases; Humans; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrazole | 2019 |
Factors in the pathogenesis of the brain damage and anaemia in the Lesch-Nyhan syndrome.
Topics: Adenine; Anemia, Macrocytic; Anemia, Megaloblastic; Animals; Bone Marrow; Brain Diseases; Erythrocyt | 1977 |
Reversible impairment of cerebral DNA synthesis in thiamine deficiency.
Topics: Adenine; Animals; Brain; Brain Diseases; Carbon Radioisotopes; DNA; Female; Hypothermia; Organ Size; | 1975 |
Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo.
Topics: Adenine; Animals; Antiviral Agents; Brain Diseases; Herpes Simplex; Injections; Injections, Intraper | 1989 |